Heparin, non-heparin glycosaminoglycans, and heparinoids: an overview of their application in atherosclerosis.
Engelberg
H
H
California Arteriosclerosis Research Foundation, Beverly Hills 90210.
D000818:Animals; D001161:Arteriosclerosis / Q000188:drug therapy*; D003327:Coronary Disease / Q000188:drug therapy; D006025:Glycosaminoglycans / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006493:Heparin / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006496:Heparinoids / Q000138:chemical synthesis / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans
D006025:Glycosaminoglycans; D006496:Heparinoids; D006493:Heparin